St. John's Wort

Generic Name: St. John's Wort

Drug Type: Biotech

CAS Number: 84082-80-4

Unique Ingredient Identifier: UFH8805FKA

Overview

No overview information available.

Indication

No indication information available.

Associated Conditions

Anxiety
Burns first degree
Depression
Dermabrasion
Dermatitis
Hot Flashes
Insomnia
Myalgia
Obsessive Compulsive Disorder (OCD)
Seasonal Affective Disorder (SAD)
Somatic Symptom Disorders

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Low Dose St John's Wort for Depression	2022/07/28	NCT05477472	N/A	Completed	Ceres Heilmittel AG
Pilot Study on Intra-abdominal Photodynamic Diagnosis in Peritoneal Carcinosis	2016/07/21	NCT02840331	Phase 3	UNKNOWN	University Hospital Tuebingen
Boceprevir and Ucalm (St John&Apos;s Wort)	2012/08/13	NCT01663922	Phase 1	Completed	St Stephens Aids Trust
Pharmacodynamic Study on Efficacy of Clopidogrel With St. John's Wort	2011/04/07	NCT01330589	Not Applicable	Withdrawn	Lancaster General Hospital
Influence of Cytochrome CYP3A4-induction by St. John's Wort on the Steady State Pharmacokinetics of Ambrisentan	2011/03/09	NCT01311362	N/A	Completed	Gerd Mikus
Influence of CYP3A4-induction by St. John's Wort on the Steady State Pharmacokinetics of Bosentan	2010/12/13	NCT01258504	N/A	Completed	Gerd Mikus
A Placebo-Controlled Trial of St. John's Wort for Irritable Bowel Syndrome	2008/01/08	NCT00587860	Phase 2	Completed	Mayo Clinic
St. John's Wort in the Treatment of Raynaud's Phenomenon	2006/07/12	NCT00351117	Phase 3	Completed	Lawson Health Research Institute
St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer	2005/05/04	NCT00110136	Phase 2	Terminated	Wake Forest University Health Sciences
Drug Interaction Study of Tegretol (Carbamazepine) and St. John's Wort in Normal Volunteers	2002/12/10	NCT00006395	Phase 4	Completed	National Institutes of Health Clinical Center (CC)

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
Arnica Echinacea	Uriel Pharmacy, Inc	48951-1406	TOPICAL	5 [hp_X] in 1 g	9/8/2025

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

Related News

No news found

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.